SW-682 in Advanced Solid Tumors

Clinical trial NCT06251310 · RECRUITING

Trial details

NCT number: NCT06251310
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Mesothelioma, Malignant

Start date: 2024-07-31
Primary completion: 2027-01-18
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.